Cargando…
A functional Notch–survivin gene signature in basal breast cancer
INTRODUCTION: Basal-type, or triple-negative, breast cancer (lacking estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 expression) is a high-risk disease for which no molecular therapies are currently available. We studied genetic signatures of basal breast cance...
Autores principales: | Lee, Connie W, Simin, Karl, Liu, Qin, Plescia, Janet, Guha, Minakshi, Khan, Ashraf, Hsieh, Chung-Cheng, Altieri, Dario C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656893/ https://www.ncbi.nlm.nih.gov/pubmed/19025652 http://dx.doi.org/10.1186/bcr2200 |
Ejemplares similares
-
CASPASE 2-MEDIATED TUMOR SUPPRESSION INVOLVES SURVIVIN GENE SILENCING
por: Guha, Minakshi, et al.
Publicado: (2009) -
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors
por: Faversani, Alice, et al.
Publicado: (2014) -
Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005) -
Notch Cooperates with Survivin to Maintain Stemness and to Stimulate Proliferation in Human Keratinocytes during Ageing
por: Palazzo, Elisabetta, et al.
Publicado: (2015) -
Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin
por: Jiang, Yuying, et al.
Publicado: (2008)